CA Stock MarketDetailed Quotes

WAVE Waverley Pharma Inc

Watchlist
  • 0.015
  • 0.0000.00%
15min DelayMarket Closed Feb 13 16:00 ET
810.00KMarket Cap-0.38P/E (TTM)

Waverley Pharma Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-93.83%22.42K
0
-66.95%412.09K
76.30%316K
6.27%363.37K
-64.77%148.59K
-60.95%118.69K
-28.87%1.25M
-61.60%179.24K
-10.66%341.93K
Operating revenue
-93.83%22.42K
--0
-66.95%412.09K
76.30%316K
6.27%363.37K
-64.77%148.59K
-60.95%118.69K
-28.87%1.25M
-61.60%179.24K
-10.66%341.93K
Cost of revenue
-96.66%7.84K
0
-65.50%332.29K
78.14%260.85K
9.89%234.75K
-86.93%46.43K
-52.80%116.87K
-37.06%963.04K
-67.75%146.43K
-34.53%213.62K
Gross profit
-88.66%14.58K
0
-71.88%79.8K
68.08%55.16K
0.24%128.62K
53.92%102.16K
-96.77%1.82K
27.45%283.79K
156.68%32.82K
127.38%128.31K
Operating expense
-19.53%773.49K
-31.02%225.67K
42.49%1.31M
253.04%1.01M
419.27%961.25K
46.81%328.09K
43.55%327.17K
-8.67%921.95K
-5.08%285.44K
-14.20%185.11K
Selling and administrative expenses
-53.18%370.11K
-41.09%160.83K
-0.90%1.13M
207.53%882.21K
90.44%790.55K
25.81%271.69K
28.85%273.01K
15.69%1.14M
-4.86%286.87K
95.95%415.11K
Research and development costs
136.31%403.38K
19.71%64.84K
187.28%234.58K
181.82%174.45K
3,560.75%170.7K
649.12%56.4K
237.83%54.17K
218.68%81.66K
7,837.38%61.9K
19.69%4.66K
Other taxes
----
----
83.57%-48.95K
----
----
----
----
---297.99K
---63.33K
---234.66K
Operating profit
8.85%-758.91K
30.64%-225.67K
-93.35%-1.23M
-277.06%-952.54K
-1,365.74%-832.63K
-43.81%-225.93K
-89.58%-325.36K
18.89%-638.16K
12.26%-252.62K
64.34%-56.81K
Net non-operating interest income (expenses)
-133.34%-110.92K
-176.87%-32.44K
-360.71%-76.65K
-470.50%-56.21K
-1,099.24%-47.54K
-1,135.85%-15.37K
-642.52%-11.72K
-447.84%-16.64K
-257.60%-9.85K
-741.61%-3.96K
Non-operating interest expense
133.34%110.92K
176.87%32.44K
----
----
1,099.24%47.54K
----
--11.72K
----
----
--3.96K
Total other finance cost
----
----
360.71%76.65K
----
----
1,135.85%15.37K
----
447.84%16.64K
----
----
Other net income (expenses)
-16.77%-12.04K
-142.13%-6.02K
-9,741.75%-913.51K
-1,741.90%-905.34K
83.09%-10.31K
-99.74%347
98.20%-2.49K
-39.70%-9.28K
143.55%55.14K
-948.01%-60.94K
Gain on sale of security
-16.77%-12.04K
-142.13%-6.02K
93.77%-578
-86.23%7.59K
83.09%-10.31K
-99.74%347
98.20%-2.49K
80.91%-9.28K
385.15%55.14K
-948.01%-60.94K
Special income (charges)
----
----
---942.62K
----
----
----
----
--0
----
----
-Less:Impairment of capital assets
----
----
--942.62K
----
----
----
----
--0
----
----
Other non-operating income (expenses)
----
----
--29.69K
----
----
----
----
----
----
----
Income before tax
0.97%-881.87K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
-631.63%-890.48K
-902.23%-240.96K
-9.19%-339.56K
16.63%-664.08K
22.65%-207.33K
26.50%-121.71K
Income tax
Earnings from equity interest net of tax
Net income
0.97%-881.87K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
-631.63%-890.48K
-902.23%-240.96K
-9.19%-339.56K
16.63%-664.08K
22.65%-207.33K
26.50%-121.71K
Net income continuous operations
0.97%-881.87K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
-631.63%-890.48K
-902.23%-240.96K
-9.19%-339.56K
16.63%-664.08K
22.65%-207.33K
26.50%-121.71K
Noncontrolling interests
Net income attributable to the company
0.97%-881.87K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
-631.63%-890.48K
-902.23%-240.96K
-9.19%-339.56K
16.63%-664.08K
22.65%-207.33K
41.27%-121.71K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
0.97%-881.87K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
-631.63%-890.48K
-902.23%-240.96K
-9.19%-339.56K
16.63%-664.08K
22.65%-207.33K
41.27%-121.71K
Diluted earnings per share
0.00%-0.02
51.09%-0.0049
-300.00%-0.04
-0.03
-787.31%-0.02
-902.70%-0.0045
0.00%-0.01
0.00%-0.01
0
41.27%-0.0023
Basic earnings per share
0.00%-0.02
51.09%-0.0049
-300.00%-0.04
-0.03
-787.31%-0.02
-902.70%-0.0045
0.00%-0.01
0.00%-0.01
0
41.27%-0.0023
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q3)Sep 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -93.83%22.42K0-66.95%412.09K76.30%316K6.27%363.37K-64.77%148.59K-60.95%118.69K-28.87%1.25M-61.60%179.24K-10.66%341.93K
Operating revenue -93.83%22.42K--0-66.95%412.09K76.30%316K6.27%363.37K-64.77%148.59K-60.95%118.69K-28.87%1.25M-61.60%179.24K-10.66%341.93K
Cost of revenue -96.66%7.84K0-65.50%332.29K78.14%260.85K9.89%234.75K-86.93%46.43K-52.80%116.87K-37.06%963.04K-67.75%146.43K-34.53%213.62K
Gross profit -88.66%14.58K0-71.88%79.8K68.08%55.16K0.24%128.62K53.92%102.16K-96.77%1.82K27.45%283.79K156.68%32.82K127.38%128.31K
Operating expense -19.53%773.49K-31.02%225.67K42.49%1.31M253.04%1.01M419.27%961.25K46.81%328.09K43.55%327.17K-8.67%921.95K-5.08%285.44K-14.20%185.11K
Selling and administrative expenses -53.18%370.11K-41.09%160.83K-0.90%1.13M207.53%882.21K90.44%790.55K25.81%271.69K28.85%273.01K15.69%1.14M-4.86%286.87K95.95%415.11K
Research and development costs 136.31%403.38K19.71%64.84K187.28%234.58K181.82%174.45K3,560.75%170.7K649.12%56.4K237.83%54.17K218.68%81.66K7,837.38%61.9K19.69%4.66K
Other taxes --------83.57%-48.95K-------------------297.99K---63.33K---234.66K
Operating profit 8.85%-758.91K30.64%-225.67K-93.35%-1.23M-277.06%-952.54K-1,365.74%-832.63K-43.81%-225.93K-89.58%-325.36K18.89%-638.16K12.26%-252.62K64.34%-56.81K
Net non-operating interest income (expenses) -133.34%-110.92K-176.87%-32.44K-360.71%-76.65K-470.50%-56.21K-1,099.24%-47.54K-1,135.85%-15.37K-642.52%-11.72K-447.84%-16.64K-257.60%-9.85K-741.61%-3.96K
Non-operating interest expense 133.34%110.92K176.87%32.44K--------1,099.24%47.54K------11.72K----------3.96K
Total other finance cost --------360.71%76.65K--------1,135.85%15.37K----447.84%16.64K--------
Other net income (expenses) -16.77%-12.04K-142.13%-6.02K-9,741.75%-913.51K-1,741.90%-905.34K83.09%-10.31K-99.74%34798.20%-2.49K-39.70%-9.28K143.55%55.14K-948.01%-60.94K
Gain on sale of security -16.77%-12.04K-142.13%-6.02K93.77%-578-86.23%7.59K83.09%-10.31K-99.74%34798.20%-2.49K80.91%-9.28K385.15%55.14K-948.01%-60.94K
Special income (charges) -----------942.62K------------------0--------
-Less:Impairment of capital assets ----------942.62K------------------0--------
Other non-operating income (expenses) ----------29.69K----------------------------
Income before tax 0.97%-881.87K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M-631.63%-890.48K-902.23%-240.96K-9.19%-339.56K16.63%-664.08K22.65%-207.33K26.50%-121.71K
Income tax
Earnings from equity interest net of tax
Net income 0.97%-881.87K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M-631.63%-890.48K-902.23%-240.96K-9.19%-339.56K16.63%-664.08K22.65%-207.33K26.50%-121.71K
Net income continuous operations 0.97%-881.87K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M-631.63%-890.48K-902.23%-240.96K-9.19%-339.56K16.63%-664.08K22.65%-207.33K26.50%-121.71K
Noncontrolling interests
Net income attributable to the company 0.97%-881.87K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M-631.63%-890.48K-902.23%-240.96K-9.19%-339.56K16.63%-664.08K22.65%-207.33K41.27%-121.71K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 0.97%-881.87K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M-631.63%-890.48K-902.23%-240.96K-9.19%-339.56K16.63%-664.08K22.65%-207.33K41.27%-121.71K
Diluted earnings per share 0.00%-0.0251.09%-0.0049-300.00%-0.04-0.03-787.31%-0.02-902.70%-0.00450.00%-0.010.00%-0.01041.27%-0.0023
Basic earnings per share 0.00%-0.0251.09%-0.0049-300.00%-0.04-0.03-787.31%-0.02-902.70%-0.00450.00%-0.010.00%-0.01041.27%-0.0023
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.